Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP

Pituitary adenylate cyclase-activating polypeptide (PACAP) is an endogenous peptide with neuroprotective effects on retinal neurons, but the precise mechanism underlying these effects remains unknown. Considering the abundance of mitochondria in retinal ganglion cells (RGCs), we postulate that the protective effect of PACAP is associated with the regulation of mitochondrial function. RGC-5 cells were subjected to serum deprivation for 48 hours to induce apoptosis in the presence or absence of 100 nM PACAP. As revealed with the Cell Counting Kit-8 assay, PACAP at different concentrations significantly increased the viability of RGC-5 cells. PACAP also inhibited the excessive generation of reactive oxygen species in RGC-5 cells subjected to serum deprivation. We also showed by flow cytometry that PACAP inhibited serum deprivation-induced apoptosis in RGC-5 cells. The proportions of apoptotic cells and cells with mitochondria depolarization were significantly decreased with PACAP treatment. Western blot assays demonstrated that PACAP increased the levels of Bcl-2 and inhibited the compensatory increase of PAC1. Together, these data indicate protective effects of PACAP against serum deprivation-induced apoptosis in RGCs, and that the mechanism of this action is associated with maintaining mitochondrial function.

[1]  T. Hirabayashi,et al.  Pleiotropic and retinoprotective functions of PACAP , 2016, Anatomical Science International.

[2]  H. Vaudry,et al.  Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase‐activating polypeptide against hydrogen peroxide‐induced oxidative damages in cultured rat astrocytes , 2016, Journal of neurochemistry.

[3]  S. Shioda,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) contributes to the proliferation of hematopoietic progenitor cells in murine bone marrow via PACAP-specific receptor , 2016, Scientific Reports.

[4]  H. Hara,et al.  Neuroprotective Effect of Ocular Hypotensive Drugs: Latanoprost/Timolol in Combination Are More Effective than Each as Monotherapy in RGC-5. , 2016, Biological & pharmaceutical bulletin.

[5]  A. Tamas,et al.  Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway , 2016, Neurotoxicity Research.

[6]  M. Cordeiro,et al.  Current perspective of neuroprotection and glaucoma , 2015, Clinical ophthalmology.

[7]  C. DeLisi,et al.  Igf1 and Pacap rescue cerebellar granule neurons from apoptosis via a common transcriptional program , 2015, Cell Death Discovery.

[8]  Grazia Maugeri,et al.  PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina , 2015, Journal of Molecular Neuroscience.

[9]  Fuli Liu,et al.  Therapeutic potential of PACAP for neurodegenerative diseases , 2015, Cellular & molecular biology letters.

[10]  E. Kowalczyk,et al.  The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation , 2015, Pharmacological reports : PR.

[11]  N. Osborne,et al.  The effect of visual blue light on mitochondrial function associated with retinal ganglions cells. , 2014, Experimental eye research.

[12]  Rong-jie Yu,et al.  Neuroprotection of a Novel Cyclopeptide C*HSDGIC* from the Cyclization of PACAP (1–5) in Cellular and Rodent Models of Retinal Ganglion Cell Apoptosis , 2014, PloS one.

[13]  E. Reiman,et al.  Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity , 2014, Neurobiology of Aging.

[14]  Nathan A. Bihlmeyer,et al.  Transcellular degradation of axonal mitochondria , 2014, Proceedings of the National Academy of Sciences.

[15]  R. Gábriel,et al.  PAC1-expressing structures of neural retina alter their PAC1 isoform splicing during postnatal development , 2014, Cell and Tissue Research.

[16]  A. Tamas,et al.  PACAP promotes neuron survival in early experimental diabetic retinopathy , 2014, Neurochemistry International.

[17]  K. So,et al.  Oligomeric proanthocyanidin protects retinal ganglion cells against oxidative stress-induced apoptosis , 2013, Neural regeneration research.

[18]  S. Scuderi,et al.  Antiproliferative Effects of PACAP and VIP in Serum-Starved Glioma Cells , 2013, Journal of Molecular Neuroscience.

[19]  D. Ji,et al.  Sulphur antioxidants inhibit oxidative stress induced retinal ganglion cell death by scavenging reactive oxygen species but influence nuclear factor (erythroid-derived 2)-like 2 signalling pathway differently. , 2013, Biological & pharmaceutical bulletin.

[20]  Makoto Nakamura,et al.  Loss of aquaporin 9 expression adversely affects the survival of retinal ganglion cells. , 2013, The American journal of pathology.

[21]  R. Gallego-Pinazo,et al.  Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma. , 2013, Current opinion in pharmacology.

[22]  N. Osborne,et al.  Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma. , 2013, Current opinion in pharmacology.

[23]  David J. Calkins,et al.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma , 2012, Progress in Retinal and Eye Research.

[24]  F. Drago,et al.  Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats , 2012, Peptides.

[25]  Rong-jie Yu,et al.  Effects of cyclopeptide C*HSDGIC* from the cyclization of PACAP (1–5) on the proliferation and UVB-induced apoptosis of the retinal ganglion cell line RGC-5 , 2012, Peptides.

[26]  S. Govoni,et al.  Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough. , 2012, Pharmacological research.

[27]  Jing Shen,et al.  Annexin 1 protects against apoptosis induced by serum deprivation in transformed rat retinal ganglion cells , 2012, Molecular Biology Reports.

[28]  A. Tamas,et al.  Protective Effects of Vasoactive Intestinal Peptide (VIP) in Ischemic Retinal Degeneration , 2012, Journal of Molecular Neuroscience.

[29]  A. Tamas,et al.  Protective effects of the neuropeptide PACAP in diabetic retinopathy , 2012, Cell and Tissue Research.

[30]  A. Tamas,et al.  Protective effects of the neuropeptide PACAP in diabetic retinopathy , 2012, Cell and Tissue Research.

[31]  Z. Tan,et al.  Hypoxia induces beta-amyloid in association with death of RGC-5 cells in culture. , 2011, Biochemical and biophysical research communications.

[32]  H. Vaudry,et al.  Pituitary adenylate cyclase‐activating polypeptide protects astroglial cells against oxidative stress‐induced apoptosis , 2011, Journal of neurochemistry.

[33]  B. Bradley,et al.  Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor , 2011, Nature.

[34]  V. Cardile,et al.  Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells , 2010, Peptides.

[35]  K. Kang,et al.  Sulbutiamine Counteracts Trophic Factor Deprivation Induced Apoptotic Cell Death in Transformed Retinal Ganglion Cells , 2010, Neurochemical Research.

[36]  J. Crowston,et al.  A comparison of differentiation protocols for RGC-5 cells. , 2010, Investigative ophthalmology & visual science.

[37]  F. Gallyas,et al.  Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects , 2010, Annals of the New York Academy of Sciences.

[38]  H. Vaudry,et al.  Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. , 2009, Current medicinal chemistry.

[39]  J. Crowston,et al.  Recharacterization of the RGC-5 retinal ganglion cell line. , 2009, Investigative ophthalmology & visual science.

[40]  G. Rasi,et al.  PACAP and VIP prevent apoptosis in schwannoma cells , 2008, Brain Research.

[41]  S. Shioda,et al.  Suppression of Ganglion Cell Death by PACAP Following Optic Nerve Transection in the Rat , 2008, Journal of Molecular Neuroscience.

[42]  S. Orrenius.  Reactive Oxygen Species in Mitochondria-Mediated Cell Death , 2007, Drug metabolism reviews.

[43]  F. Gallyas,et al.  Involvement of ERK and CREB Signaling Pathways in the Protective Effect of PACAP in Monosodium Glutamate‐Induced Retinal Lesion , 2006, Annals of the New York Academy of Sciences.

[44]  A. Izzotti,et al.  The role of oxidative stress in glaucoma. , 2006, Mutation research.

[45]  P. Ježek,et al.  Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. , 2005, The international journal of biochemistry & cell biology.

[46]  N. Cooper,et al.  Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways. , 2005, Investigative ophthalmology & visual science.

[47]  S. Shioda,et al.  PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. , 2002, Current protein & peptide science.

[48]  R. Linden,et al.  Pituitary Adenylyl Cyclase-activating Polypeptide Prevents Induced Cell Death in Retinal Tissue through Activation of Cyclic AMP-dependent Protein Kinase* , 2002, The Journal of Biological Chemistry.

[49]  A. García-Osta,et al.  BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons , 2001, Neuroreport.

[50]  S. Shioda,et al.  Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse , 2010, Journal of Molecular Neuroscience.

[51]  S. Shioda,et al.  Suppression of Rat Retinal Ganglion Cell Death by PACAP Following Transient Ischemia Induced by High Intraocular Pressure , 2010, Journal of Molecular Neuroscience.